NASDAQ
Apimeds Pharmaceuticals US, Inc (APUS) has a current ratio of 1.31x as of Monday, May 25, 2026. This represents a 73.37% decrease compared to its 12-month average of 4.90x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.